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rug-Eluting Stent Thrombosis
e read with interest the article by Liu et al. (1) comparing
ntravascular ultrasound findings from definite drug-eluting stent
hrombosis patients with in-stent restenosis (ISR) patients with no
vidence of stent thrombosis and “no-event” patients with neither
hrombosis nor ISR. The authors demonstrated that minimum
tent area and stent expansion were significantly smaller in the
tent thrombosis group versus ISR and in both groups versus the
no-event” group.
Because underexpansion is associated with both technique/
perator-related factors (undersized balloon size, low balloon
ressure, and short duration of inflation) and lesion-related factors
vessel size; plaque volume; and plaque composition, especially
alcification), it is sometimes difficult to achieve optimal stent
xpansion even with large balloon size, high balloon pressure, and
ong duration of inflation (2,3). To clarify this point, it would be
aluable to know intravascular ultrasound (IVUS) data after repeat
rocedure. If stent expansion was little improved even with the use
f higher balloon pressures and/or larger balloons, underexpansion
eemed to be associated with lesion-related factors. In such
atients, additional (pharmacological) intervention may be needed.
Interestingly, IVUS examination at baseline was performed in 6
f 20 patients with stent thrombosis and in 15 of 50 patients with
SR, a similar rate with 16 of 50 “no-event” patients. A recent
tudy demonstrated that IVUS-directed bare-metal stent place-
ent does not significantly reduce the 12-month target lesion
evascularization rate (4). To determine interaction between un-
erexpansion and IVUS guidance on outcome, it would be of great
elp if the authors would provide data to compare stent expansion
n patients with baseline IVUS examination and that in patients
ithout.
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tent Expansion at the
egment With Thrombus
ith great interest I read the article by Otake et al. (1) assessing
he determinants of subclinical thrombus after sirolimus-eluting
tent implantation using optical coherence tomography. The
uthors demonstrated that average stent eccentricity index (mini-
um/maximum stent diameter) and stent length were associated
ith the presence of thrombus. The authors speculate that “asym-
etric stent expansion affects thrombus formation in part due to
neven stent coverage and healing.” To examine local determi-
ants on the presence of thrombus, an additional within-patient
nalysis may be helpful. Was stent expansion more asymmetric at
or near) the segment with thrombus than that at the segment
ithout thrombus in a patient?
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eply
e thank Dr. Kaneda for his interest and comments on our recent
ublication (1). Dr. Kaneda suggested an additional within-patient
nalysis comparing stent expansion index (SEI) (minimum/
aximum stent diameter) between segments with and without
hrombus. This is an important suggestion to examine more local
eterminants on the presence of thrombus.
In our study, we demonstrated that the average SEI was
ssociated with the presence of subclinical thrombus after
irolimus-eluting stent (SES) implantation (SEI: SES with throm-
